trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of +2.90% per trade.
trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +4.10% per trade.
Copying Veda Pharmyne's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +11.15% per trade.
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +11.15% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
SNPHY Analyst Recommendation Trends
Rating
Dec 19
Jun 20
Jan 25
Apr 25
Oct 25
Strong Buy
0
0
0
0
0
Buy
0
0
1
2
2
Hold
1
2
2
1
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
1
2
3
3
3
In the current month, SNPHY has received 2Buy Ratings, 1Hold Ratings, and 0Sell Ratings. SNPHY average Analyst price target in the past 3 months is ―.
Each month's total comprises the sum of three months' worth of ratings.
SNPHY Stock Forecast FAQ
What is SNPHY’s average 12-month price target, according to analysts?
Currently, no data Available
What is SNPHY’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for SNPHY, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is SNPHY a Buy, Sell or Hold?
Santen Pharmaceutical Co Ltd has a consensus rating of Hold which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
What is Santen Pharmaceutical Co Ltd’s price target?
Currently, no data Available
What do analysts say about Santen Pharmaceutical Co Ltd?
Santen Pharmaceutical Co Ltd’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
How can I buy shares of SNPHY?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.